Efficacy and safety of triple-antiplatelet therapy after percutaneous coronary intervention: a meta-analysis.

Author: FuZhao-xin, LiJin, TangHai-qin, ZhangYong

Paper Details 
Original Abstract of the Article :
The combination of cilostazol, aspirin and clopidogrel (triple antiplatelet therapy, TAT) after a percutaneous coronary intervention has been used as an alternative therapy. We performed a meta-analysis to evaluate the efficacy and safety of TAT for patients after percutaneous coronary intervention ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/23652062

データ提供:米国国立医学図書館(NLM)

Triple-Antiplatelet Therapy After Percutaneous Coronary Intervention: A Meta-Analysis

Percutaneous coronary intervention (PCI) is a common procedure used to treat heart disease. This meta-analysis examines the efficacy and safety of triple-antiplatelet therapy (TAT), a combination of cilostazol, aspirin, and clopidogrel, following PCI. The research delves into the complexities of managing heart disease, much like navigating a vast desert with its diverse terrain and potential challenges.

Evaluating the Effectiveness of Triple-Antiplatelet Therapy

The meta-analysis synthesized data from multiple studies to assess the effectiveness of TAT in patients who underwent PCI. The findings provide insights into the potential benefits and risks of this treatment approach, helping clinicians make informed decisions about patient care.

Navigating the Landscape of Cardiovascular Care

This research sheds light on the evolving landscape of cardiovascular care and the need for evidence-based approaches to managing heart disease. It's like a caravan traversing a desert: it's crucial to have a map, a compass, and a reliable guide to ensure a successful journey.

Dr.Camel's Conclusion

This meta-analysis provides valuable information regarding the use of triple-antiplatelet therapy after PCI. It's a reminder that ongoing research and evidence-based practices are critical in managing cardiovascular health. It's like a compass guiding us through the vast desert of medical knowledge.

Date :
  1. Date Completed 2014-01-24
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

23652062

DOI: Digital Object Identifier

23652062

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.